Innovating Works

SOCIEDAD ANONIMA SISTEL

Activa
PROTEUS: Predicting Routes Of Tumour Evolution driven by Unstable genomes and Selection SOCIEDAD ANONIMA SISTEL participó en un H2020: ERC-2018-ADG Despite progress in cancer drug development, the majority of patients who present with advanced, metastatic, solid tumours have incurable di...
2019-05-14 - 2024-11-30 | Financiado
DiSCo MRI SFN: Developing Integrated Susceptibility and Conductivity MRI for Next Generation Structural and Functio... SOCIEDAD ANONIMA SISTEL participó en un H2020: ERC-2017-COG MRI is indispensable in the diagnosis of neurodegenerative diseases. These are poorly understood while their prevalence and socio-economic b...
2018-10-31 - 2025-09-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.